Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast

Guillermo Elizondo, Pedro Fernandez-Salguero, M. Saeed Sheikh, Geum-Yi Kim, Albert J. Fornace, Kyung S. Lee and Frank J. Gonzalez
Molecular Pharmacology May 2000, 57 (5) 1056-1063;
Guillermo Elizondo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Fernandez-Salguero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Saeed Sheikh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geum-Yi Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert J. Fornace
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyung S. Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank J. Gonzalez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The aryl hydrocarbon receptor (AHR) is known to mediate the toxic and carcinogenic effects of polycyclic aromatic hydrocarbons and dioxins. High-affinity AHR ligands, such as 2,3,7,8-tetrachlorodibenzeno-p-dioxin, have been shown to modify cell proliferation and differentiation. However, the mechanisms by which AHR affects cell proliferation and differentiation are not fully understood. To investigate the role of AHR in cell proliferation, mouse embryonic fibroblasts (MEFs) derived from AHR-null mice were obtained and characterized. Compared with wild-type MEFs, AHR-null cells exhibited a lower proliferation rate with an accumulation of 4N DNA content and increased apoptosis. The expression levels of Cdc2 and Plk, two kinases important for G2/M phase of cell cycle, were down-regulated in AHR-null MEFs. In contrast, transforming growth factor-β (TGF-β), a proliferation inhibitor in several cell lines, was present at high levels in conditioned medium from AHR-null MEFs. Concomitant with G2/M cell accumulation, treatment of wild-type MEFs with TGF-β3 also resulted in down-regulation of both Cdc2 and Plk. Thus, overproduction of TGF-β in AHR-deficient cells appears to be the primary factor that causes low proliferation rates and increased apoptosis. Taken together, these results suggest that AHR influences TGF-β production, leading to an alteration in cell cycle control.

Footnotes

  • Send reprint requests to: Dr. Frank J. Gonzalez, Laboratory of Metabolism, National Cancer Institute, Building 37, Room 3E24, Bethesda, MD 20892. E-mail:fjgonz{at}helix.nih.gov

  • ↵1 Present address: Departado Farmacologia y Toxicologia, Instituto Politecnico Nacional, San Pedro Zacatenco, Mexico DF CP 07730.

  • ↵2 Laboratorio de Bioquimica y Biologia Molecular, Facultad de Ciencias, Universidad de Extremadura, 06071 Badajoz, Spain.

  • Abbreviations:
    AHR
    aryl hydrocarbon receptor
    HAH
    halogenated aromatic hydrocarbon
    MEF
    mouse embryonic fibroblast
    DMEM
    Dulbecco's modified Eagle's medium
    DAPI
    4′-diamino-2-phenylindole
    TCDD
    2,3,7,8-tetrachlorodibenzeno-p-dioxin
    TGF-β
    transforming growth factor-β
    • Received September 15, 1999.
    • Accepted January 5, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (5)
Molecular Pharmacology
Vol. 57, Issue 5
1 May 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast

Guillermo Elizondo, Pedro Fernandez-Salguero, M. Saeed Sheikh, Geum-Yi Kim, Albert J. Fornace, Kyung S. Lee and Frank J. Gonzalez
Molecular Pharmacology May 1, 2000, 57 (5) 1056-1063;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast

Guillermo Elizondo, Pedro Fernandez-Salguero, M. Saeed Sheikh, Geum-Yi Kim, Albert J. Fornace, Kyung S. Lee and Frank J. Gonzalez
Molecular Pharmacology May 1, 2000, 57 (5) 1056-1063;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics